In April 2018, Creavis launched the Tissue Engineering Project House in Singapore, making it Evonik’s twelfth project house.

Up to 20 scientists from various disciplines will work at the Tissue Engineering Project House to make reliable solutions possible for tissue regeneration following accidents, disease, etc. The aim is to develop materials for biological implants in medical applications.

According to expert estimates, the market for the materials needed in the field of tissue engineering is growing by roughly 30 percent per year and will reach the US $3 billion mark by 2021. Tissue engineering refers to the growth of living cells on a scaffold material, for which they require special nutrients and growth factors. The goal is to grow tissue outside of the organism and then implant it as a way of creating or regenerating bones, cartilage, tendons, or even arteries.

Evonik has extensive experience with materials such as biodegradable polymers suitable for use as scaffold materials for tissue replacement. The company intends to grow this expertise in close collaboration with the Medical Devices Competence Center in Birmingham (Alabama, USA). One potential area for the Tissue Engineering Project House to explore in the future is the use of 3D-printed scaffold materials to reproduce desired tissue structures to repair injuries, for instance.

Another focus is on optimizing the conditions under which tissue cells grow on the scaffold materials. In addition to its knowledge of the media needed and of the ingredients that go into those media (amino acids, etc.), Evonik also has exceptional expertise in the field of biotechnology. Another goal is to take advantage of the excellent innovation environment in Singapore, which is home to cutting-edge research on 3D printing and top universities in the field of medical research.